scispace - formally typeset
E

Ethan Bornstein

Researcher at National Institutes of Health

Publications -  11
Citations -  4191

Ethan Bornstein is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Cytotoxic T cell & Antigen. The author has an hindex of 7, co-authored 8 publications receiving 3710 citations.

Papers
More filters
Journal ArticleDOI

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

TL;DR: It is shown that increased lipopolysaccharide is bioactive in vivo and correlates with measures of innate and adaptive immune activation, which establish a mechanism for chronic immune activation in the context of a compromised gastrointestinal mucosal surface and provide new directions for therapeutic interventions that modify the consequences of acute HIV infection.
Journal ArticleDOI

Epidemiologic and Clinical Characteristics of Monkeypox Cases — United States, May 17–July 22, 2022

David H. Philpott, +115 more
TL;DR: Clinicians should test patients with rash consistent with monkeypox,† regardless of whether the rash is disseminated or was preceded by prodrome, and public health efforts should prioritize gay, bisexual, and other men who have sex with men, who are currently disproportionately affected for prevention and testing.
Journal ArticleDOI

TCR β-Chain Sharing in Human CD8+ T Cell Responses to Cytomegalovirus and EBV

TL;DR: The results suggest that TCRβ production frequency plays an important role in the interindividual sharing of TCR β sequences within CD8+ T cell responses specific for CMV and EBV.
Journal ArticleDOI

Detection of low avidity CD8+ T cell populations with coreceptor-enhanced peptide-major histocompatibility complex class I tetramers

TL;DR: These findings provide the first validation of a novel approach to the physical detection of low avidity antigen-specific CD8(+) T cell populations; such coreceptor-enhanced multimeric reagents are likely to be useful in a multitude of settings for the detection of auto-immune, tumor-specific and cross-reactive CD8 (+) T cells.